Results 31 to 40 of about 5,685 (219)
Cureus, 2022 Eptifibatide is a platelet glycoprotein (GP) IIb/IIIa inhibitor that is used in certain cases of acute coronary syndrome, including those with high thrombus burden or with no-reflow.
Zaid Gheith, Areej Kilani, Tam Nguyen
semanticscholar +1 more source
Early versus delayed, provisional eptifibatide in acute coronary syndromes [PDF]
, 2009 BACKGROUND: Glycoprotein IIb/IIIa inhibitors are indicated in patients with acute coronary syndromes who are undergoing an invasive procedure. The optimal timing of the initiation of such therapy is unknown.
Giugliano, RP +9 more
core +2 more sources
Application of eptifibatide injection in acute ischemic cerebrovascular disease [PDF]
Xin yixue, 2022 Objective To evaluate the treatment effectiveness and safety of eptifibatide injection in the treatment of acute ischemic cerebrovascular disease （ICVD）.
Mei Ni, Tian Liang
doaj +1 more source
Drug-Induced Immune Thrombocytopenia Secondary to Trimethoprim-Sulfamethoxazole. [PDF]
Case Rep Infect DisWe report the case of a 55‐year‐old male with AIDS who developed severe thrombocytopenia following initiation of trimethoprim–sulfamethoxazole. Despite drug discontinuation and supportive measures, thrombocytopenia persisted, leading to the patient’s death.
Cimperman C +6 more
europepmc +2 more sources
Journal of Interventional Medicine, 2020 Objective: To compare the antiplatelet effect and major adverse cerebrovascular events of Pipeline for intracranial aneurysms using glycoprotein IIb/IIIa antagonists (GPI) eptifibatide and tirofiban.
Qiao Deng +4 more
doaj +1 more source
Experimental and Therapeutic Medicine, 2022 Progressive ischemic stroke (PIS) is a therapeutic challenge in clinical practice. The present retrospective study aimed to investigate the safety and effectiveness of eptifibatide in the treatment of PIS.
Longfeng Luo +5 more
semanticscholar +1 more source
International Journal of Applied Pharmaceutics, 2021 Objective: The objective of the present study is to develop a stability-indicating reverse-phase high-performance liquid chromatography (RP-HPLC) method for qualitative and quantitative determination of Eptifibatide and its impurities in bulk and ...
K. Girija +2 more
semanticscholar +1 more source
Eptifibatide-induced acute profound thrombocytopenia: A case report
Medicine, 2022 Rationale: Eptifibatide is an antiplatelet agent used in the medical management of acute coronary syndrome. Although multiple studies did not reveal a significant association between eptifibatide and the development of thrombocytopenia, recent case ...
Mohammed A. Alamin +4 more
semanticscholar +1 more source
International Journal of Nanomedicine, 2022 Purpose In the search for new drug delivery platforms for cardiovascular diseases and coating of medical devices, we synthesized eptifibatide-functionalized silver nanoparticles (AgNPs-EPI) and examined the pharmacological activity of AgNPs-EPI on ...
Justyna Hajtuch +8 more
semanticscholar +1 more source
Low-Dose Eptifibatide for Tandem Occlusion in Stroke: Safety and Carotid Artery Patency
American Journal of Neuroradiology, 2021 BACKGROUND AND PURPOSE: Maintaining carotid patency and avoiding symptomatic intracranial hemorrhage are competing concerns in tandem occlusions. This study provides data regarding the safety and efficacy of eptifibatide in stroke from tandem occlusion ...
A. Jost +4 more
semanticscholar +1 more source